Overview

* Masimo Q3 2025 GAAP revenue grows 8.2%, beating analyst expectations

* Non-GAAP EPS for Q3 grows 38% yr/yr, reflecting operational efficiency

* Company, during qtr, sold Sound United to Harman, proceeds used for stock repurchases

Outlook

* Masimo ( MASI ) expects for cont ops 2025 non-GAAP revenue of $1,510 to $1,530 mln

* Company projects for cont ops 2025 non-GAAP EPS of $5.62 to $5.79 excluding tariffs impact

Result Drivers

* SALES GROWTH - Co attributes Q3 revenue growth to positive momentum in core healthcare business and innovative products

* OPERATING EFFICIENCY - Improved operating margin and EPS growth attributed to successful efficiency initiatives

* STRATEGIC PARTNERSHIP - Expansion of partnership with Philips expected to support long-term growth

Key Details

Metric Beat/Mis Actual Consensu

s s

Estimate

Q3 Beat $371.5 $366.84

Revenue mln mln (8

Analysts

)

Analyst Coverage

* The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 7 "strong buy" or "buy", 2 "hold" and no "sell" or "strong sell"

* The average consensus recommendation for the medical equipment, supplies & distribution peer group is "buy"

* Wall Street's median 12-month price target for Masimo Corp ( MASI ) is $182.50, about 20.6% above its November 3 closing price of $144.96

* The stock recently traded at 25 times the next 12-month earnings vs. a P/E of 29 three months ago

Press Release:

For questions concerning the data in this report, contact [email protected]. For any other questions or feedback, contact .

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)